ID

31746

Descripción

APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00652340

Link

https://clinicaltrials.gov/show/NCT00652340

Palabras clave

Versiones (1)
  1. 25/9/18 25/9/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

25 de septiembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Recurrent Non Small Cell Lung Cancer NCT00652340

Inglés

Eligibility Recurrent Non Small Cell Lung Cancer NCT00652340

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologically determined stage iv nsclc including stage iiib (pleural effusion)
Descripción

Non-Small Cell Lung Carcinoma TNM clinical staging | Pleural effusion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C0032227
failed at least one prior platinum-based chemotherapy for stage iiib or stage iv nsclc. patients receiving platinum-based chemotherapy only given in an adjuvant setting are not eligible.
Descripción

Chemotherapy Platinum-Based Quantity failed | Non-Small Cell Lung Carcinoma TNM clinical staging | Adjuvant Chemotherapy Platinum-Based Ineligible

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1514162
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0231175
UMLS CUI [2,1]
C0007131
UMLS CUI [2,2]
C3258246
UMLS CUI [3,1]
C0085533
UMLS CUI [3,2]
C1514162
UMLS CUI [3,3]
C1512714
measurable disease by recist
Descripción

Measurable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
greater than or equal to 18 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ecog ps of 0 or 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
radiation therapy within 2 weeks; chemotherapy within 3 weeks; non-cytotoxic investigational agents within 4 weeks of initiating study treatment
Descripción

Therapeutic radiology procedure | Chemotherapy | Investigational New Drugs | Exception Cytotoxic agent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0392920
UMLS CUI [3]
C0013230
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0304497
evidence of nyha class iii or greater cardiac disease
Descripción

Heart Disease New York Heart Association Classification

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C1275491
history of mi, stroke, ventricular arrhythmia, or symptomatic conduction abnormality within 12 months
Descripción

Myocardial Infarction | Cerebrovascular accident | Ventricular arrhythmia | Cardiac conduction abnormality Symptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0085612
UMLS CUI [4,1]
C1842820
UMLS CUI [4,2]
C0231220
known hiv infection or aids
Descripción

HIV Infection | AIDS

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0001175
symptomatic cns metastases
Descripción

CNS metastases Symptomatic

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0231220
pregnant or nursing women
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
hypersensitivity or intolerance to erlotinib, sulfonamides, aspirin, or other nsaids.
Descripción

Hypersensitivity Erlotinib | Intolerance to Erlotinib | Allergy to sulfonamides | Intolerance to Sulfonamides | Aspirin allergy | Intolerance to Aspirin | Allergy to nonsteroidal anti-inflammatory agents | Intolerance to NSAIDs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1135135
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C1135135
UMLS CUI [3]
C0038757
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0038760
UMLS CUI [5]
C0004058
UMLS CUI [6,1]
C1744706
UMLS CUI [6,2]
C0004057
UMLS CUI [7]
C0746949
UMLS CUI [8,1]
C1744706
UMLS CUI [8,2]
C0003211
history of upper gi bleeding, ulceration, or perforation
Descripción

Upper gastrointestinal hemorrhage | Upper Gastrointestinal Tract Ulceration | Upper gastrointestinal perforation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0041909
UMLS CUI [2,1]
C3203348
UMLS CUI [2,2]
C3887532
UMLS CUI [3]
C0749862
prior history of cox-2 inhibitor therapy for the treatment of metastatic nsclc
Descripción

Cyclooxygenase 2 Inhibitors | Therapeutic procedure Non-small cell lung cancer metastatic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1257954
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0278987
previous anti-egfr kinase therapy
Descripción

EGFR Tyrosine Kinase Inhibitor Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3899317
Volver a la parte superior de la página

Similar models

Eligibility Recurrent Non Small Cell Lung Cancer NCT00652340

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma TNM clinical staging | Pleural effusion
Item
pathologically determined stage iv nsclc including stage iiib (pleural effusion)
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0032227 (UMLS CUI [2])
Chemotherapy Platinum-Based Quantity failed | Non-Small Cell Lung Carcinoma TNM clinical staging | Adjuvant Chemotherapy Platinum-Based Ineligible
Item
failed at least one prior platinum-based chemotherapy for stage iiib or stage iv nsclc. patients receiving platinum-based chemotherapy only given in an adjuvant setting are not eligible.
boolean
C0392920 (UMLS CUI [1,1])
C1514162 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C0007131 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3,1])
C1514162 (UMLS CUI [3,2])
C1512714 (UMLS CUI [3,3])
Measurable Disease
Item
measurable disease by recist
boolean
C1513041 (UMLS CUI [1])
Age
Item
greater than or equal to 18 years of age
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog ps of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure | Chemotherapy | Investigational New Drugs | Exception Cytotoxic agent
Item
radiation therapy within 2 weeks; chemotherapy within 3 weeks; non-cytotoxic investigational agents within 4 weeks of initiating study treatment
boolean
C1522449 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C0304497 (UMLS CUI [4,2])
Heart Disease New York Heart Association Classification
Item
evidence of nyha class iii or greater cardiac disease
boolean
C0018799 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Myocardial Infarction | Cerebrovascular accident | Ventricular arrhythmia | Cardiac conduction abnormality Symptomatic
Item
history of mi, stroke, ventricular arrhythmia, or symptomatic conduction abnormality within 12 months
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0085612 (UMLS CUI [3])
C1842820 (UMLS CUI [4,1])
C0231220 (UMLS CUI [4,2])
HIV Infection | AIDS
Item
known hiv infection or aids
boolean
C0019693 (UMLS CUI [1])
C0001175 (UMLS CUI [2])
CNS metastases Symptomatic
Item
symptomatic cns metastases
boolean
C0686377 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity Erlotinib | Intolerance to Erlotinib | Allergy to sulfonamides | Intolerance to Sulfonamides | Aspirin allergy | Intolerance to Aspirin | Allergy to nonsteroidal anti-inflammatory agents | Intolerance to NSAIDs
Item
hypersensitivity or intolerance to erlotinib, sulfonamides, aspirin, or other nsaids.
boolean
C0020517 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C1135135 (UMLS CUI [2,2])
C0038757 (UMLS CUI [3])
C1744706 (UMLS CUI [4,1])
C0038760 (UMLS CUI [4,2])
C0004058 (UMLS CUI [5])
C1744706 (UMLS CUI [6,1])
C0004057 (UMLS CUI [6,2])
C0746949 (UMLS CUI [7])
C1744706 (UMLS CUI [8,1])
C0003211 (UMLS CUI [8,2])
Upper gastrointestinal hemorrhage | Upper Gastrointestinal Tract Ulceration | Upper gastrointestinal perforation
Item
history of upper gi bleeding, ulceration, or perforation
boolean
C0041909 (UMLS CUI [1])
C3203348 (UMLS CUI [2,1])
C3887532 (UMLS CUI [2,2])
C0749862 (UMLS CUI [3])
Cyclooxygenase 2 Inhibitors | Therapeutic procedure Non-small cell lung cancer metastatic
Item
prior history of cox-2 inhibitor therapy for the treatment of metastatic nsclc
boolean
C1257954 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0278987 (UMLS CUI [2,2])
EGFR Tyrosine Kinase Inhibitor Therapy
Item
previous anti-egfr kinase therapy
boolean
C3899317 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial